Balance Sheet Data

Ekso Bionics Holdings, Inc. (EKSO)

$ 3.3481
-0.01 (-0.35%)

Year
A/P
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Total Cash 16.8527.817.6610.8712.8613.7213.4613.2112.9612.71
Total Cash (%)
Account Receivables 1.782.763.665.213.392.752.702.652.602.55
Account Receivables (%)
Inventories 1.563.033.372.491.982.132.092.052.011.97
Inventories (%)
Accounts Payable 1.882.423.161.901.501.821.791.751.721.69
Accounts Payable (%)
Capital Expenditure -1.10-0.46-0.13-0.06-0.34-0.34-0.33-0.32-0.32-0.31
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.